No Association of Trichomonas vaginalis Seropositivity with Advanced Prostate Cancer Risk in the Multiethnic Cohort: A Nested Case-Control Study
- PMID: 37958367
- PMCID: PMC10648031
- DOI: 10.3390/cancers15215194
No Association of Trichomonas vaginalis Seropositivity with Advanced Prostate Cancer Risk in the Multiethnic Cohort: A Nested Case-Control Study
Abstract
The potential involvement of a sexually transmitted agent has been suggested to contribute to the high number of prostate cancers in the United States and worldwide. We investigated the relationship of Trichomonas vaginalis seropositivity with prostate cancer risk in a nested case-control study within the Multiethnic Cohort in Hawaii and California using blood samples collected prior to cancer diagnoses. Incident cases of advanced prostate cancer (intermediate- to high-grade based on Gleason score ≥ 7 and/or disease spread outside the prostate) were matched to controls by age, ethnicity, and the date of blood collection. T. vaginalis serostatus was measured using an ELISA detecting IgG antibodies against a recombinant T. vaginalis α-actinin protein. Seropositivity to T. vaginalis was observed in 35 of 470 (7.4%) cases and 26 of 470 (5.5%) controls (unadjusted OR = 1.47, 95% CI 0.82-2.64; adjusted OR = 1.31, 95% CI 0.67-2.53). The association was similarly not significant when cases were confined to extraprostatic tumors having regional or distant spread (n = 121) regardless of grade (unadjusted OR = 1.37, 95% CI 0.63-3.01; adjusted OR = 1.20, 95% CI 0.46-3.11). The association of T. vaginalis with prostate cancer risk did not vary by aspirin use. Our findings do not support a role for T. vaginalis in the etiology of advanced prostate cancer.
Keywords: Trichomonas vaginalis; advanced prostate cancer; prostate; prostate cancer; trichomoniasis.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Trichomonas vaginalis serostatus and prostate cancer risk in Egypt: a case-control study.Parasitol Res. 2021 Apr;120(4):1379-1388. doi: 10.1007/s00436-020-06942-7. Epub 2020 Nov 7. Parasitol Res. 2021. PMID: 33159459
-
Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study.J Natl Cancer Inst. 2009 Oct 21;101(20):1406-11. doi: 10.1093/jnci/djp306. Epub 2009 Sep 9. J Natl Cancer Inst. 2009. PMID: 19741211 Free PMC article.
-
Trichomonas vaginalis infection and risk of prostate cancer: associations by disease aggressiveness and race/ethnicity in the PLCO Trial.Cancer Causes Control. 2017 Aug;28(8):889-898. doi: 10.1007/s10552-017-0919-6. Epub 2017 Jul 1. Cancer Causes Control. 2017. PMID: 28669054 Free PMC article.
-
Inflammatory response to Trichomonas vaginalis in the pathogenesis of prostatitis and benign prostatic hyperplasia.Parasites Hosts Dis. 2023 Feb;61(1):2-14. doi: 10.3347/PHD.22160. Epub 2023 Feb 22. Parasites Hosts Dis. 2023. PMID: 37170459 Free PMC article. Review.
-
Infinity war: Trichomonas vaginalis and interactions with host immune response.Microb Cell. 2023 Mar 30;10(5):103-116. doi: 10.15698/mic2023.05.796. eCollection 2023 May 1. Microb Cell. 2023. PMID: 37125086 Free PMC article. Review.
Cited by
-
The Past, Present, and Future in the Diagnosis of a Neglected Sexually Transmitted Infection: Trichomoniasis.Pathogens. 2024 Jan 29;13(2):126. doi: 10.3390/pathogens13020126. Pathogens. 2024. PMID: 38392864 Free PMC article. Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources